Evidence map›Paper›PMID 28295178›Full record

ReviewBritish journal of haematology2017

Granulocyte transfusions in the management of invasive fungal infections.

Kamille A West, Juan Gea-Banacloche, David Stroncek, Sameer S Kadri

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of haematology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 60 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Mucormycosis.Infectious disease clinics of North America · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Case report: AFrontiers in oncology · 2022
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Kamille A WestDepartment of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.ORCID 0000-0001-8152-804X
Juan Gea-BanaclocheExperimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MD, USA.
David StroncekDepartment of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.
Sameer S KadriCritical Care Medicine Department, National Institutes of Health Clinical Center, Bethesda, MD, USA.
National Institutes of Health Clinical Center · USNational Cancer Institute · US

Funding

Development of novel cell and gene therapiesZIACL002120 · CLC · CLINICAL CENTER · PI STRONCEK, DAVID · 2009 to 2025
$0k
Intramural NIH HHS Z99 CL999999
6 · The paper itself

Abstract

Granulocyte transfusions have a long history of being used in patients with neutropenia or neutrophil dysfunction to prevent and treat invasive fungal infections. However, there are limited and conflicting data concerning its clinical effectiveness, considerable variations in current granulocyte transfusion practices, and uncertainties about its benefit as an adjunct to modern antifungal therapy. In this review, we provide an overview on granulocyte transfusions and summarize the evidence on their role in the prevention and treatment of invasive fungal infections.

Indexed as

Donor SelectionEvidence-Based MedicineGranulocytesHumansInvasive Fungal InfectionsLeukocyte TransfusionNeutrophilsfungal infectiongranulocytesleukapheresisneutropeniatransfusions

Identifiers

PMID28295178
PMCPMC5403628
OpenAlexW2607594356

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.